ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

Seven Seats Open Up On NCAB

January 17, 1986

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002